UK markets open in 2 hours 18 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,413.79 +206.66 (+1.14%) CRUDE OIL
79.18 +0.23 (+0.29%) GOLD FUTURES
2,314.20 +4.60 (+0.20%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,494.17 +1,708.84 (+3.73%)
MorphoSys AG (MOR.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 09:45PM CEST
| Previous close | 65.20 |
| Open | 65.10 |
| Bid | 66.05 x 27700 |
| Ask | 66.35 x 21000 |
| Day's range | 65.00 - 66.20 |
| 52-week range | 14.90 - 67.95 |
| Volume | |
| Avg. volume | 7,418 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 14 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireMorphoSys AG Reports First Quarter 2024 Financial Results
PLANEGG/MUNICH, Germany, April 29, 2024--MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2024.
ZacksNovartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.
- Zacks
Novartis (NVS) to Undertake Job Cuts in Development Department
Novartis (NVS) is set to cut jobs by 680 in its development organization to reshape workforce.
© 2024 Yahoo. All rights reserved.